Effects of ibuprofen on plasma endothelin levels and some vital parameters during endotoxin shock in rabbits

Clinica Chimica Acta

Volumn 316, Issue 1-2, 2002, Pages 101-108

  Vural, Pervin ^a,c   Canbaz, Mukaddes ^a   Akbulut, Ayhan ^b   Celik, Ilhami ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c Hakan Apt No: 4/4 ^*  (Turkey)

Author keywords

Ibuprofen; Plasma endothelin; Rabbits

Indexed keywords

ENDOTHELIN; ENDOTOXIN; IBUPROFEN;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART RATE; LIPID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RABBIT; SEPTIC SHOCK;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; ENDOTHELINS; HEART RATE; IBUPROFEN; RABBITS; SHOCK, SEPTIC; TIME FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036136592     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00740-9     Document Type: Article

References (35)

1. Hemodynamic determinants of mortality in human septic shock
2. The role of endothelin in coronary atherosclerosis
3. Pathophysiologic role of endothelin-1 in renal functions in rats with endotoxin shock
4. Dynamic study of nitric oxide and endothelin-1 during endotoxin shock and their effects of their antagonism on hemodynamics
5. Thermal injury alters endothelial vasoconstrictor and vasodilator response to endotoxin
6. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis
7. Plasma concentrations of TNF-alpha, endothelin-1 and thrombomodulin in patients with sepsis
8. Circulating endothelin-1 and tumor necrosis factor-α: Early predictors of mortality in patients with septic shock
9. The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice
10. Free radicals and myocardial ischemia and reperfusion injury
11. Biology of the disease: Free radicals and tissue injury
12. Oxygen-derived free radicals in postischemic tissue injury
13. Functional modification of vascular endothelial cells by cytokines during septic shock
14. Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase
15. Lipid peroxidation and myocardial ischemia
16. Prostaglandins in physiological and certain pathological responses of the cerebral circulation
17. Ibuprofen prevents Pasteurella hemolytica endotoxin-induced changes in plasma prostanoids and serotonin, and fever in sheep
18. Ibuprofen in canine endotoxin shock
19. Modification, by aspirin and indomethacin, of the hemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog
20. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells
21. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells
22. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia
23. Escherichia coli endotoxin injections potentiate experimental ischemic renal injury
24. Biochemical, physiological and clinical aspects of endotoxemia
25. Ibuprofen intervention in canine septic shock: Reduction of pathophysiology without decreased cytokines
26. Interleukin-1 increases the production of endothelin-1 in cultured endothelial cells
27. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes
28. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages
29. Enhancement of neutrophil superoxide production by preincubation with human tumor necrosis factor
30. Elevation of plasma endothelin concentrations during endotoxin shock in dogs
31. Ibuprofen in patients with severe sepsis
32. Analgesics - Antipyretics drugs as antagonists of endotoxic shock in dogs
33. Inhibition of cyclo-oxygenase attenuates the metabolic response to the endotoxin in humans
34. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
35. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors